Zobrazeno 1 - 10
of 308
pro vyhledávání: '"V J, Suman"'
Publikováno v:
Mayo Clinic Proceedings. 73:10-16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::235beb662334258f33c6f22f5cf26f88
https://doi.org/10.4065/73.1.10
https://doi.org/10.4065/73.1.10
Autor:
Zhang, Peng1,2,3 (AUTHOR) zhangpeng2295@zjcc.org.cn, Tao, Changjuan4,5 (AUTHOR), Lu, Ye3 (AUTHOR), Li, Peijing4,5 (AUTHOR), Wang, Xing6 (AUTHOR), Dai, Yujie7 (AUTHOR), Xi, Yun8 (AUTHOR), Shimura, Takaya9 (AUTHOR), Li, Xinfang7 (AUTHOR), Fang, Jianmin10 (AUTHOR), Yang, Liu1,2 (AUTHOR) yangliu@hmc.edu.cn, He, Dawei11 (AUTHOR) hedawei@hospital.cqmu.edu.cn, Guo, Peng3 (AUTHOR) guopeng@ucas.ac.cn
Publikováno v:
Advanced Science. 8/14/2024, Vol. 11 Issue 30, p1-19. 19p.
Autor:
A T, Baron, J M, Lafky, V J, Suman, D W, Hillman, M C, Buenafe, C H, Boardman, K C, Podratz, E A, Perez, N J, Maihle
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(11)
Soluble ErbB (sErbB) growth factor receptors are being investigated as cancer biomarkers. Gonadotropic and steroid hormones have been shown to modulate the expression of ERBB family members in vivo. Accordingly, the range of sErbB1 values and their r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c05de79cf03bac027c98faaeea5016ac
https://pubmed.ncbi.nlm.nih.gov/11700266
https://pubmed.ncbi.nlm.nih.gov/11700266
Autor:
W. J. Maples, V. J. Suman, Hui Tang, Robert C. Smallridge, C. Erlichman, K. C. Bible, P. J. Flynn, Kostandinos Sideras, Anne M. Traynor, K. P. Webster, Carolyn Bieber, B. C. Goh, Jill K. Burton, J. C. Morris rd, Julian R. Molina, Michele Marinò, J. Rubin, B. McIver, Michael E. Menefee, S. P. Ivy
Publikováno v:
L'Endocrinologo. 11:235-236
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed143234d355f39cdfa48b6df59b19be
https://doi.org/10.1007/bf03344753
https://doi.org/10.1007/bf03344753
Autor:
M, Hanson Frost, V J, Suman, T A, Rummans, A M, Dose, M, Taylor, P, Novotny, R, Johnson, R E, Evans
Publikováno v:
Psycho-oncology. 9(3)
While research exists on the well-being of women during a specific phase of breast cancer, little research exists in which researchers utilized the same instruments to examine differences in women's well-being, based on the phase of their breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::42d3206edefcda561362494f4b3cb739
https://pubmed.ncbi.nlm.nih.gov/10871718
https://pubmed.ncbi.nlm.nih.gov/10871718
Autor:
J N, Ingle, V J, Suman, P A, Johnson, J E, Krook, J A, Mailliard, R H, Wheeler, C L, Loprinzi, E A, Perez, V C, Jordan, M, Dowsett
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(7)
The goals of this clinical trial involving postmenopausal women with metastatic breast cancer were to: (a) examine the effects of letrozole on tamoxifen (TAM) pharmacokinetics; (b) examine estrogen suppression in patients receiving TAM plus letrozole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8da16609ccbba9c209376bde47145a9e
https://pubmed.ncbi.nlm.nih.gov/10430063
https://pubmed.ncbi.nlm.nih.gov/10430063
Autor:
J N, Ingle, V J, Suman, C G, Kardinal, J E, Krook, J A, Mailliard, M H, Veeder, C L, Loprinzi, R J, Dalton, L C, Hartmann, C A, Conover, M N, Pollak
Publikováno v:
Cancer. 85(6)
Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2462e9c9f00ab0c2e32975c9dcb1a696
https://pubmed.ncbi.nlm.nih.gov/10189133
https://pubmed.ncbi.nlm.nih.gov/10189133
Autor:
A T, Baron, J M, Lafky, C H, Boardman, S, Balasubramaniam, V J, Suman, K C, Podratz, N J, Maihle
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 8(2)
Epithelial ovarian cancer (EOC) has a high mortality rate, which is due primarily to the fact that early clinical symptoms are vague and nonspecific; hence, this disease often goes undetected and untreated until in its advanced stages. Sensitive and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::29385e38e35e2e7b9ece109593bdc8af
https://pubmed.ncbi.nlm.nih.gov/10067810
https://pubmed.ncbi.nlm.nih.gov/10067810
Autor:
J B, Lawrence, C A, Conover, T C, Haddad, J N, Ingle, J M, Reid, M M, Ames, V J, Suman, R S, Marks, C, Erlichman, L C, Hartmann
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(10)
Suramin represents a new class of antitumor drugs that targets growth factor networks. In this Phase II trial, suramin was administered by continuous infusion to 10 patients with advanced breast cancer. The target level of 280 microgram/ml suramin wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7a9c7d7263b243e7af5b4a37e58e587c
https://pubmed.ncbi.nlm.nih.gov/9815555
https://pubmed.ncbi.nlm.nih.gov/9815555
Publikováno v:
Cancer. 83(9)
In contrast to female breast carcinoma, information regarding the prevalence and prognostic information of new molecular markers is limited in male breast carcinoma. The objective of this study was to assess the degree of expression and prognostic va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fae0fb9700cc79be7f2f6be81ea15e4d
https://pubmed.ncbi.nlm.nih.gov/9806653
https://pubmed.ncbi.nlm.nih.gov/9806653